Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY -2.61%66 EPS without NRI is $0.39 as of Mar. 2026. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Surgery Partners ranks better than 84.62% on this metric.
Surgery Partners's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $-0.03.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.39.
During the past 12 months, Surgery Partners's average earnings per share (NRI) Growth Rate was -55.70% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 43.20% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Surgery Partners's EPS without NRI or its related term are showing as below:
SGRY'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -33.8 Med: 43.2 Max: 128.6
Current: 43.2
During the past 13 years, Surgery Partners's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 128.60% per year. The lowest was -33.80% per year. And the median was 43.20% per year.
SGRY's 3-Year EPS without NRI Growth Rate is ranked better than 84.62% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs SGRY: 43.20
Surgery Partners's EPS (Diluted) for the
three
months ended in Mar. 2026 was $-0.28.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.60.
Surgery Partners's EPS (Basic) for the
three
months ended in Mar. 2026 was $-0.28.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.60.
Surgery Partners (NAS:SGRY) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Surgery Partners EPS without NRI Related Terms
Surgery Partners EPS without NRI Historical Data
* Premium members only.
The historical data trend for Surgery Partners's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGRY vs AVAH, ASTH, ADUS: EPS without NRI Comparison
For the Medical Care Facilities subindustry, Surgery Partners's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Surgery Partners's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a EPS without NRI of $0.39 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Surgery Partners and its competitors. According to the industry distribution chart, Surgery Partners ranks #78 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 15.4%.
Is Surgery Partners' EPS without NRI too high?
Surgery Partners' current EPS without NRI is $0.39. The Healthcare Providers & Services industry median EPS without NRI is 11.10. Surgery Partners' value of $0.39 is 96.5% below this industry median. Based on the distribution chart, Surgery Partners ranks #78 out of 507 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' EPS without NRI compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #78 out of 507 companies for EPS without NRI. This places Surgery Partners in the top 15% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.10. Surgery Partners' value of $0.39 is 96.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.10, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current EPS without NRI of $0.39 is 96.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current EPS without NRI is $0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current EPS without NRI is $0.39 and 96.5% below the Healthcare Providers & Services industry median of 11.10. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Surgery Partners (SGRY), the current EPS without NRI is $0.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
EPS without NRI: $0.39
GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
Industry Position: 96.5% below the Healthcare Providers & Services median (#78 of 507)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
